Single Photon Emission Computed Tomography (SPECT) with circular containment tube at biosafety level 4 (BSL-4) laboratory of the NIAID Integrated Research Facil
National Institute of Allergy and Infectious Diseases (Wikimedia Commons) / Public domain
Clinical Trials/October 15, 2026/3 min read

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

  • Drawing and Writing Activities in Adolescents With Type 1 Diabetes — RECRUITING, NA. Interventions: Drawing and Writing Intervention. Locations: Ankara, Ankara, Turkey (Türkiye). This randomized controlled trial aims to evaluate the effects of drawing and writing activities on anxiety an...Source
  • Fasted Exercise Training in Type 1 Diabetes (FED-T1D) — RECRUITING, NA. Interventions: Fasted Exercise, Postprandial Exercise. Locations: Edmonton, Alberta, Canada. This study compares aerobic exercise training performed before breakfast (i.e., in the fasted state) to simila...Source
  • Establishment of Screening Pathway for High-Risk Population of Type 1 Diabetes — RECRUITING. Interventions: Gene polymorphic detection. Locations: Beijing, Beijing Municipality, China. This study aims to establish a system for identifying and screening high-risk individuals for type 1 diabetes (T1D)...Source
  • A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers — RECRUITING, PHASE4. Interventions: XWRAP. Locations: Hollywood, Florida, United States. A multicenter, prospective, controlled clinical trial evaluating the efficacy of a single layer placental-based allograft and stand...Source
  • A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States — RECRUITING. Interventions: Teplizumab. Locations: San Francisco, California, United States. This study is an observational, longitudinal, non-interventional real-world study in the United States. The study is meant to d...Source
  • A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D Patients — RECRUITING. Locations: Petah Tikva, Israel. A national Screening program for the presence of Islet Autoantibodies (IA) in relatives of people with type 1 diabetes (PWT1D) aiming at identifying people with pre-clinical (...Source
  • Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes — RECRUITING. Interventions: No intervention. Locations: Leuven, Belgium. A registry of individuals with type 1 diabetes that visited the Department of Endocrinology of the University Hospitals of Leuven is established. T...Source
  • Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy — RECRUITING. Interventions: Skin biopsies with quantification of intra-epidermal nerve fibre density, Perception Threshold Tracking, Thermal perception thresholds. Locations: Aalborg, Denmark. Predicting early onset neur...Source

Questions before contacting a study

  • Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
  • What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
  • Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.